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Introduction
Systemic sclerosis (SSc) is an autoimmune rheumatic 
disease characterized by fibrosis of the skin and internal organs
due to excessive collagen production and vasculitis of small
arteries. The prevalence of SSc is estimated between 3 and 
24 cases per 100,000 people [1]. Female gender and African ori-
gin are risk factors for SSc [1].
Avascular necrosis (AVN) or osteonecrosis is bone death due to
the disturbance of the vascular supply to the bone [2]. The incidence
of AVN is approximately 3/100,000 [3], of which 3% involves the
foot or ankle, whereas the hip is involved in 75.9% of  cases [4]. AVN
is often caused by a traumatic event but can also have an atraumat-
ic cause such as the use of corticosteroids, alcoholism, hyperlipi-
demia, hemoglobinopathies/thrombophilia or diabetes mellitus. 
As the treatment of systemic causes often includes cortico-
steroids, determining the exact cause can prove to be challenging. We
present a case in which  SSc can be identified as the causal factor in
AVN since the patient did not receive any treatment with cortico-
steroids or had other concurrent pathology that may induce AVN.
Case Report
A 67-year-old woman complained of invalidating pain in the
left foot that started spontaneously one year ago. She had a history of
peripheral polyneuropathy, abdominal pain, acrosclerosis and pul-
monary hypertension in the context of systemic sclerosis. She was
treated with pulmonary vasodilators (macitentan, tadalafil),
asaflow, bumetanide (Burinex), spironolactone, rosuvastatin and
analgesics. She had not previously received any glucocorticoids.
On examination there was a pronounced swelling of both the
ankle and the foot. The alignment was neutral, but weight bearing
was not possible. There were inflammatory signs of dolor and calor,
but no erythema. The functional assessment was limited due to pain.
Palpation showed pronounced non-specific tenderness. The neu-
rovascular examination showed limited hyporeflexia and mild deep
sensory disturbance without clearly abnormal electromyogram. 
Previous radiographs showed no other structural abnormalities
but mild osteopenia and limited subchondral sclerosis 
(Fig. 1A). A Tc-99m HDP bone scintigraphy one month after the
onset of the symptoms (one year before consultation) showed a hot
spot in the talus, which was interpreted as a stress fracture (Fig. 2A).
Supportive treatment with a walker boot provided initial symptom
relief. However, due to ongoing discomfort 6 months later, a new
bone scintigraphy was performed, which showed an active arthropa-
thy mainly in the calcaneocuboid and subtalar joints (Fig. 2B).
Finally, an additional MRI was performed seven months after the
radiographs, which showed extensive AVN of different bones in the
hind-, mid- and forefoot and of the tibia (Fig. 1B; Fig. 1C).
Maximum conservative treatment was opted for with limited
weightbearing, a walking boot and pain medication. One year after
the onset of the symptoms, the mobility and function of the joints is
intact, and she has weaned off the walking boot. 
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This review describes a case of atraumatic avascular necrosis in the foot and ankle in a patient with systemic sclerosis who did not receive cor-
ticosteroid therapy. Both avascular necrosis and systemic sclerosis are uncommon disease entities. This case demonstrates that vasculitis and
secondary vasoconstriction in the pathogenesis of systemic sclerosis are important risk factors for the development of avascular necrosis of the
foot and ankle. Therefore, if these patients develop chronic foot and ankle pain, avascular necrosis should be included in the differential diag-
nosis, even if they do not receive corticosteroids. For the diagnosis and follow-up of avascular necrosis MRI remains the gold standard. Thus,
MRI should be used to diagnose avascular necrosis in an early stage. 
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Discussion
This case highlights the importance of considering AVN in
the differential diagnosis in patients with chronic foot and ankle
pain. AVN is caused by a disruption of the blood flow to the
bone. This can be caused by a variety of processes including trau-
matic or compressive arterial inflow disruption, venous outflow
obstruction or intraluminal vascular occlusion [2]. Trauma is a
frequent cause of AVN in the femoral head, humeral head,
scaphoid and talus. Besides trauma, AVN can also have an atrau-
matic cause such as the use of corticosteroids, alcoholism,
hyperlipidemia, hemoglobinopathy/thrombophilia, diabetes
mellitus or irradiation. If there is a systemic cause, such as sys-
temic lupus erythematosus (SLE), multifocal infarctions of the
foot and ankle can occur [2, 5, 6]. There are several case reports
that describe an association between SSc and AVN, which is
most commonly observed in the hip [7–9] and lunate bone
[10–12]. However, only two cases of SSc with AVN of the foot
are briefly mentioned in literature [13, 14]. In both cases, the
talus was affected. In one of these cases multiple joints were
affected, namely both hips and both taluses, and the patient
never received any corticosteroids either [13]. In the second
case, no specific information was given about concurrent AVN in
other bones of the foot or other joints, on the use of corticos-
teroids or on the use of MRI for the diagnosis of AVN [14]. 
In systemic sclerosis (SSc), the characteristic changes in
blood vessels are well known and are caused by three separate
processes [15]. First, autoantibodies are produced, and cell-
mediated autoimmunity is activated by abnormalities in the
innate and adaptive immune system. Second, defective endothe-
lial cells and fibroproliferative vasculopathy of small blood ves-
sels develop. The damage to the endothelial cells leads to vaso-
constriction (influenced by endothelin) and to obliteration of the
micro-and macrovasculature. Finally, because of fibrogenic
characteristics of endothelin and the abnormal fibroblast growth,
qualitatively normal collagen is excessively produced. These
three mechanisms affect all blood vessels in the body. For
instance, vasculitis induced vasoconstriction can cause pul-
monary hypertension and abdominal angina. Both the macro-
and microvascular effects of vasculitis could be the cause of spo-
radic occurrence of AVN in SSc, similarly to the pathogenesis of
acral osteolysis in SSc. Treatment with corticosteroids is also a
known risk factor for developing AVN, but vasculitis itself and
vasoconstriction are separate risk factors for AVN development
and play an important role in its pathogenesis. Therefore, the
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Fig. 1. Radiographic and MRI Images of the Left Foot and Ankle.
(A) Lateral and Anteroposterior Radiographic Images of the Left
Foot and Ankle: the arrows indicate areas of limited osteopenia
and subchondral sclerosis, which corresponds to stage II of avas-
cular necrosis. (B) Sagittal T2-Weighted MRI Images and 
(C) Sagittal T1-Weighted MRI Images of the Left Foot and Ankle with
arrows indicating extensive avascular necrosis of the hind-, mid- and
base of the forefoot and the tibia, corresponding to stage II/III of AVN
Fig. 2. Three-phase HDP-99m bone scintigraphy.
(A) One month after the onset of atraumatic pain in the left ankle,
possibly corresponding to stage II/III of avascular necrosis. 
(1) Whole body scintigraphy showing increased bone turnover of
the left ankle (black arrows). (2) Coronal and (3) sagittal
SPECT/CT reconstructions of the feet in the same patient showing
a hot spot (red arrows) in the base of the talus, and a relatively
colder zone (blue arrows) in the cranial pole of the talus. 
(B) 18 months after the onset of atraumatic pain in the left ankle,
possibly corresponding to a late phase of avascular necrosis. 
(1) Whole body scintigraphy no longer showing increased bone
turnover of the left ankle (black arrows). (2) Transverse and 
(3) sagittal SPECT/CT reconstructions of the feet in the same 
patient showing active calcaneocuboid (2) and subtalar 
(3) arthropathy (white arrows), characterized by degenerative
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diagnosis of AVN should also be considered in patients with SSc
who are not receiving corticosteroids.
In atraumatic AVN, vasculopathy disrupts the blood flow
to the bone and causes oxygen deprivation in the bone tissue
(stage 0). The affected bone attempts to repair itself via reossi-
fication, revascularization and resorption of necrotic bone
(stage I-II). In severe cases the bone can collapse which caus-
es severe pain and inability to use the affected joint (stage III).
The collapsed bone often results in damage the cartilage sur-
face and causes osteoarthritis in the long term (stage IV). The
time between the onset of the first symptoms and bone collapse
can take several months to over a year. The processes of reossi-
fication and resorption in the bones affected by AVN can be
visualized using different medical imaging techniques: radiog-
raphy, Computed Tomography (CT) and Magnetic Resonance
Imaging (MRI)(2). The different stages of AVN and their 
corresponding findings on clinical examination, radiogra-
phy/CT, MRI and Tc-99m HDP bone scintigraphy with Single
Photon Emission Computed Tomography (SPECT) are sum-
marized in Table 1.
AVN appears similarly on radiography and CT. In stage 0 of
AVN, radiography and CT will not show any abnormalities of the
affected bones. This time lag between the vascular insult and visible
radiographic manifestations mirrors the underlying pathophysiology.
The interruption of the blood supply induces hyperemia in the por-
tions of the bone that are still perfused. This results in resorption of
healthy bone and causes a relative osteopenia. As the bone is further
resorbed, the contrast with the remaining necrotic bone increases. In
stage I and II, the necrotic bone appears sclerotic since it cannot be
reabsorbed anymore due to the lack of perfusion. Nevertheless, 
during reossification, new bone is laid down over the necrotic tra-
beculae which leads to further sclerosis and enlargement of the con-
trast with the healthy bone. Revascularization and resorption tend to
occur around the area of osteonecrosis, which can result in a lucent
rim around the necrotic bone. In stage III signs of bone collapse are
visible and in stage IV changes towards osteoarthritis, such as joint
space narrowing, sclerosis and osteophytosis, are visible.
While different stages of AVN can be recognized on CT, MRI
is considered the gold standard for the radiographic diagnosis of
AVN. Even in stage 0, early signs of AVN, namely bone marrow
edema, can be detected, which is not possible using CT imaging.
The bone marrow edema corresponds to a low intensity zone on
T1-weighted images and to a high intensity zone on T2-weighted
images. Histologically, bone marrow edema corresponds to
ischemic death of hematopoietic cells, endothelial cells and
lipocytes. This induces an elevated amount of extracellular fluid
in the bone. Edema can be detected two weeks after the disrup-
tion of the blood supply. In stage I and II of AVN, MRI shows
sclerosis of the bone, both on T1- and T2-weighted images. The
double-line sign is described as a typical sign in these stages. It
represents the necrotic bone and the viable granulation tissue as a
low intensity edge and a high intensity center on T2-weighted
images. The double-line sign is rarely observed in the foot and
ankle and is more frequently observed in AVN of the humeral
head and femur. Yet, in this patient the MRI of the foot does
depict the double line sign. In stage III and IV of AVN, collapse
of the bone and late changes in the affected joint are also clearly
visible on MRI.
Another type of imaging that can be used to visualize different
stages of AVN is bone scintigraphy where Tc-99m HDP uptake
represents the zones of decreased, normal or increased bone
turnover. Therefore, in stage 0 of AVN only a zone of decreased
bone turnover will be visible, the so-called «cold spot».
Nonetheless, this image is rarely captured. In stage I and II the
cold spot is still visible, representing the necrotic bone, but is now
surrounded by a zone of increased bone turnover, representing an
attempt of the body to reconstruct the bone. In stage III the cold
spot is no longer visible and is replaced by the zone of increased
bone turnover. In stage IV the bone is deformed and there is no
longer new bone formation. These imaging features for each stage
of AVN have not yet been described in the foot.
In conclusion, AVN should be considered in the differential
diagnosis of foot and ankle pain in a patient with SSc, even in the
absence of corticosteroid therapy. MRI remains the gold standard
to diagnose AVN.
Key points:
• Atraumatic avascular necrosis of the foot is a possible com-
plication of systemic sclerosis.
• Avascular necrosis should be suspected in patients with sys-
temic sclerosis who develop chronic joint pain.
• Literature suggests that vasculitis and vasoconstriction in
systemic sclerosis play an important role in the pathogene-
sis of avascular necrosis.
• MRI is the gold standard for the radiographic diagnosis of
AVN of the foot.
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Stage     Symptoms                            RX / CT                                                   MRI                                                        Bone scintigraphy
Table 1. Imaging Features of Different Stages of Avascular Necrosis
0 None Normal Bone marrow edema Cold spot
I Pain on weight support Osteopenia Osteosclerosis (double-line sign) Hot spot surrounding cold spot
II Continuous pain Osteopenia, osteosclerosis Osteosclerosis (double-line sign) Hot spot surrounding cold spot
III Irradiating pain Bone collapse Bone collapse Hot spot
IV Severe pain Bone collapse, joint destruction Bone collapse, joint destruction Bone collapse (CT)
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